Comparing Results of Five SARS-CoV-2 Antibody Assays Before and After the First Dose of ChAdOx1 nCoV-19 Vaccine among Health Care Workers
Authors:
- Seri JeongSJSeri Jeong
- Nuri LeeNLNuri Lee
- Su Kyung LeeSLSu Kyung Lee
- Eun-Jung ChoECEun-Jung Cho
- Jungwon HyunJHJungwon Hyun
- Min-Jeong ParkMPMin-Jeong Park
- Wonkeun SongWSWonkeun Song
- Eun Ju JungEJEun Ju Jung
- Heungjeong WooHWHeungjeong Woo
- Yu Bin SeoYSYu Bin Seo
- Jin Ju ParkJPJin Ju Park
- Hyun Soo KimHKHyun Soo Kim
Open Access
- 18 August 2021
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 59 (9) , e0110521
Abstract
Reliable results regarding serologic positivity for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody before and after AstraZeneca (AZ) vaccination are essential for estimating the efficacy of vaccination. We assessed positivity rates and associated factors using five SARS-CoV-2 antibody assays.Keywords
This publication has 30 references indexed in Scilit:
- Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trialThe Lancet, 2020
- Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from RussiaThe Lancet, 2020
- Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trialThe Lancet, 2020
- Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trialThe Lancet, 2020
- Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapyThe Lancet Respiratory Medicine, 2020
- COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort studyThe Lancet, 2020
- Validation and clinical evaluation of a SARS-CoV-2 surrogate virus neutralisation test (sVNT)Emerging Microbes & Infections, 2020
- Multicenter evaluation of two chemiluminescence and three lateral flow immunoassays for the diagnosis of COVID-19 and assessment of antibody dynamic responses to SARS-CoV-2 in TaiwanEmerging Microbes & Infections, 2020
- Seroprevalence of Anti-SARS-CoV-2 Antibodies among Outpatients in Southwestern Seoul, KoreaJournal of Korean Medical Science, 2020
- Defining Association between COVID-19 and the Multisystem Inflammatory Syndrome in Children through the PandemicJournal of Korean Medical Science, 2020